There is 1 paper on 19-BM in aging research: 1 observational study in people.
1 paper studies it1 finding
“The 19-BM scores achieved an AUC of 0.79, outperforming PSA (AUC 0.54, p<0.0001), ERSPC (AUC 0.63, p=0.0108), PSAD (AUC 0.61, p=0.0021) and mpMRI (AUC 0.65, p= 0.0069).”
- Humans1
Associations
1Clinically significant prostate cancer
upin humans1
1 study
Clinically significant prostate cancer
upin humans1
19-BM predicts clinically significant prostate cancer in biopsy-naive patients at risk for csPCa (AUC 0.79).
“The 19-BM scores achieved an AUC of 0.79, outperforming PSA (AUC 0.54, p<0.0001), ERSPC (AUC 0.63, p=0.0108), PSAD (AUC 0.61, p=0.0021) and mpMRI (AUC 0.65, p= 0.0069).”
Humansin biopsy-naive patients at risk for csPCa
Research SquarePreprint
Latest
1 paper in 12 monthsResearch Square
Prospective validation of a urine-based proteomics test for predicting clinically significant prostate cancer in biopsy-naive patients
Preprint: cohort study of 161 peopleProstate cancer